Subclinical inflammation and diabetic polyneuropathy

Diabetes Care

Volumn 32, Issue 4, 2009, Pages 680-682

  Herder, Christian ^a   Lankisch, Mark ^b   Ziegler, Dan ^a   Rathmann, Wolfgang ^a   Koenig, Wolfgang ^c   Illig, Thomas ^d   Döring, Angela ^d   Thorand, Barbara ^d   Holle, Rolf ^d   Giani, Guido ^a   Martin, Stephan ^a,e   Meisinger, Christa ^d  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b HELIOS KLINIKUM WUPPERTAL   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e SANA KLINIKUM OFFENBACH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; CHEMOKINE; CYTOKINE; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DISEASE MARKER; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MEDIATOR; NEUROLOGIC EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYNEUROPATHY; POPULATION; PREVALENCE; PROTEIN EXPRESSION; RISK FACTOR;

ACUTE-PHASE PROTEINS; ANALYSIS OF VARIANCE; C-REACTIVE PROTEIN; CHEMOKINES; CYTOKINES; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; GERMANY; HUMANS; INFLAMMATION; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS;

EID: 65349124102     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-2011     Document Type: Article

References (15)

1. Kolb H, Mandrup-Poulsen T: An immune origin of type 2 diabetes? Diabetologia 48: 1038-1050, 2005
2. Van Gaal LF, Mertens IL, De Block CE: Mechanisms linking obesity with cardiovascular disease. Nature 444:875-880, 2006
3. Navarro-GonzalezJF, Mora-Fernandez C: The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 19: 433-442, 2008
4. Adamis AP, Berman AJ: Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol 30:65-84, 2008
5. Matsuda M, Kawasai F, Inoue H, Kanda Y, Yamada K, Harada Y, Saito M, Eto M, Matsuki M, Kaku K: Possible contribution of adipocytokines on diabetic neuropathy. Diabetes Res Clin Pract 66 (Suppl. 1): S121-S123, 2004
6. Gonzalez-Clemente JM, Mauricio D, Richart C, Broch M, Caixas A, Megia A, Gimenez-Palop O, Simon I, Martinez- Riquelme A, Gimenez-Perez G, Vendrell J: Diabetic neuropathy is associated with activation of the TNF-alpha system in subjects with type 1 diabetes mellitus. Clin Endocrinol (Oxf) 63:525-529, 2005
7. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA: A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17:1281-1289, 1994
8. Lunetta M, Le Moli R, Grasso G, Sangiorgio L: A simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathy. Diabetes Res Clin Pract 39:165-172, 1998
9. Jia WP, Shen Q, Bao YQ, Lu JX, Li M, Xiang KS: Evaluation of the four simple methods in the diagnosis of diabetic peripheral neuropathy. Zhonghua Yi Xue Za Zhi 86:2707-2710, 2006 [in Chinese]
10. Moghtaderi A, Bakhshipour A, Rashidi H: Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clin Neurol Neurosurg 108:477-481, 2006
11. Gonzalez-Clemente JM, Vilardell C, Broch M, Megia A, Caixas A, Gimenez- Palop O, Richart C, Simon I, Martinez- Riquelme A, Arroyo J, Mauricio D, Vendrell J: Lower heart rate variability is associated with higher plasma concentrations of IL-6 in type 1 diabetes. Eur J Endocrinol 157:31-38, 2007
12. Lanza GA, Pitocco D, Navarese EP, Sestito A, Sgueglia GA, Manto A, Infusino F, Musella T, Ghirlanda G, Crea F: Association between cardiac autonomic dysfunction and inflammation in type 1 diabetic patients: effect of beta-blockade. Eur Heart J28:814-820, 2007
13. Felderhoff-Mueser U, Schmidt OI, Oberholzer A, Bührer C, Stahel PF: IL-18: a key player in neuroinflammation and neurodegeneration? Trends Neurosci 28: 487-493, 2005
14. Zhang XM, Duan RS, Chen Z, Quezada HC, Mix E, Winblad B, Zhu J: IL-18 deficiency aggravates kainic acid-induced hippocampal neurodegeneration in C57BL/6 mice due to an overcompensation by IL-12. Exp Neurol 205:64-73, 2007
15. Andoh T, Kishi H, Motoki K, Nakanishi K, Kuraishi Y, Muraguchi A: Protective effect of IL-18 on kainate- and IL-β1 -induced cerebellar ataxia in mice. J Immunol 180:2322-2328, 2008